At its second attempt, Provention Bio has secured FDA approval for teplizumab, as a treatment to delay late-stage type 1 diabetes (T1D) in at-risk individuals – becoming the first disease ...
A new treatment is changing the lives of those with early onset Type 1 Diabetes. A new drug approved by the Food and Drug ...